Skip to main content
Menu
search

Constructing Capabilities: Holistic Infrastructure Development in Decentralized Manufacturing

Constructing Capabilities: Holistic Infrastructure Development in Decentralized Manufacturing

Industry:
Biopharma

Type:
Podcast

Location:
Miami, Florida

This fifth and final panel with Sean Bartholomew (Biopharma Applications Engineer, Germfree) and Grayson Heller (COO, cGMPnow) discuss the considerations for decentralized cell therapy manufacturing. The key points include the importance of designing identical and cloned processes, focusing on a copy-paste model for multiple locations.

You might also be interested in

View all videos
Ballad Health: The Impact of Smarthood™
The Impact of Smarthood™
Ballad Health: The Impact of Smarthood™Video

Ballad Health: The Impact of Smarthood™

Discover how Ballad Health is transforming pharmacy operations across its healthcare network with Germfree’s innovative Smarthood™ technology. Hear from their dedicated team as they share how Smarthood™ has streamlined sterile…
Navigating One Year of Compliance with USP 797 and 800
Navigating One Year of Compliance with USP 797 and 800Articles

Navigating One Year of Compliance with USP 797 and 800

One year into the USP 797/800 updates, explore their impact on healthcare safety, success stories, and how Germfree supports compliance.
Advancing Patient Access Through Decentralized Manufacturing
Advancing Patient Access Through Decentralized ManufacturingVideo

Advancing Patient Access Through Decentralized Manufacturing

In this insightful discussion, Carol Houts, Chief Strategy Officer for Germfree, addresses how decentralized manufacturing is fixing the patient access barriers in the cell and gene therapy space.

Contact us: Let's unlock your scientific potential together

Complete our contact form and a member of our commercial team will contact you within 24 hours.

White email icon on a green diamond
Service & support: cs@germfree.com
Contact us